Document is current
Any future updates will be listed below
-
Authors
Militello, Giuseppe
Greig, Alyssa
Bi, Chongfeng
Vasileva, Ana
Zavodszky, Maria I.
Lo, Shih-Ching
Guilmette, Edward
Clarner, Pete
Liu, Bin
Bhat, Guruharsha
Suh, Junghae
Dow, Lukas
Zuber, Johannes
Fellmann, Christof
Premsrirut, Prem K.
- License Information
-
More Information
Article History
Received: 18 December 2024
Accepted: 12 June 2025
First Online: 1 July 2025
Declarations
:
: PP and CF are the founders of Mirimus. PP is the CEO of Mirimus. GM, AG, BC, AV, were employees at Mirimus when the study was conducted. LD and JZ are members of Mirimus’ Scientific Advisory Board. BL, GB, MZ, PC, EG, SCL, JS were employees at Biogen when the study was conducted. PP, GM, JZ, CF are inventors on a pending patent application (U.S. Patent Application No. 18/899,181) covering the amiRNAs designed and validated in this manuscript.
